TOXICOLOGY RELEVANT TO ANTICANCER DRUG DEVELOPMENT

被引：0
|
作者：
HARRAP, KR [1 ]
机构：
[1] INST CANC RES,DEPT BIOCHEM PHARMACOL,SUTTON,SURREY,ENGLAND
来源：
INVESTIGATIONAL NEW DRUGS | 1984年 / 2卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：112 / 112
页数：1
相关论文
共 50 条
  • [21] THE ROLE OF DELIVERY SYSTEMS IN TOXICOLOGY AND DRUG DEVELOPMENT
    NAU, H
    PHARMACY INTERNATIONAL, 1983, 4 (09): : 228 - 231
  • [22] Toxicogenomics: A Predictive Tool in Toxicology and Drug Development
    Hoflack, Jean-Christophe
    Roth, Adrian B.
    Suter, Laura
    DRUG METABOLISM REVIEWS, 2010, 42 : 4 - 4
  • [23] Haematotoxicology in drug development: a model of human toxicology
    Gribaldo, L
    PROGRESS IN THE REDUCTION, REFINEMENT AND REPLACEMENT OF ANIMAL EXPERIMENTATION, 2000, 31 : 671 - 677
  • [24] Moving upstream in anticancer drug development
    William N. Hait
    Peter F. Lebowitz
    Nature Reviews Drug Discovery, 2019, 18 (3) : 159 - 160
  • [25] Overview on Anticancer Drug Design and Development
    Olgen, Sureyya
    CURRENT MEDICINAL CHEMISTRY, 2018, 25 (15) : 1704 - 1719
  • [26] Calixarenes and their Relevance in Anticancer Drug Development
    Paul, Soumyajeet
    Jeyaprakash, Ramaiah Selladurai
    Pai, Aravinda
    Venkatachalam, Hillemane
    Jayashree, Bellur Srinivas
    MEDICINAL CHEMISTRY, 2023, 19 (10) : 939 - 945
  • [27] Anticancer drug development: the grand challenges
    William N. Hait
    Nature Reviews Drug Discovery, 2010, 9 : 253 - 254
  • [28] Moving upstream in anticancer drug development
    Hait, William N.
    Lebowitz, Peter F.
    NATURE REVIEWS DRUG DISCOVERY, 2019, 18 (03) : 1 - 2
  • [29] Current approaches to anticancer drug development
    Buolamwini, John
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
  • [30] NOGALAMYCIN TO MENOGAROL - DEVELOPMENT OF AN ANTICANCER DRUG
    BHUYAN, BK
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1983, 186 (AUG): : 51 - MBTD
12345